JP Morgan Cuts JBS Price Target to $17.50

JBS N.V. (JBS) business photo

Key Points

  • JP Morgan maintained its Overweight rating on JBS N.V. on October 22, 2026, shifting its price target from $18.00 down to $17.50.
  • JP Morgan's $17.50 price target implies 46.26% upside from JBS N.V.'s ($JBS) current $11.96 share price.
  • The global protein producer reported trailing twelve-month revenue of $91.17 billion alongside an earnings per share figure of $1.07.
  • Wall Street maintains a general buy consensus on the stock, with the company scheduled to report next earnings on November 9, 2026.

Get JBS N.V. text alerts

We text you when insiders, Congress, analysts or big funds move on $JBS.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated JBS N.V. alert may contain errors. Disclosures

JP Morgan maintained its Overweight rating on JBS N.V. on October 22, 2026, while lowering its price target from $18.00 to $17.50. The research note provides a forward-looking perspective on the packaged foods company from the investment bank. JBS N.V. closed at $12.27 on October 22, 2026.

JBS JBS N.V.
$12.22 -6.93% year to date
Daily close · Oct 22, 2026

JP Morgan's Call on JBS N.V.

On October 22, 2026, JP Morgan issued its research update, keeping an Overweight rating on the shares while moving its price target from $18.00 to $17.50. This follows earlier tracking from the firm on the stock, which included an $18.00 target on October 9, 2026.

Other Institutional Activity in JBS N.V.

Large institutional funds adjusted their holdings in the company during filings. Bndes Participacoes S.A. reduced its holdings by 19,931 shares, ending with 199,288,206 shares worth about $2.45 billion. Davis Selected Advisers grew its holdings by 23,772,016 shares, ending with 50,016,236 shares worth about $613.7 million for a 90.6% increase. Shaw D.E. & Co., Inc. grew its holdings by 4,886,385 shares, ending with 11,276,322 shares worth about $138.4 million for a 76.5% increase. Brandes Investment Partners L.P. grew its holdings by 4,711,186 shares, ending with 7,693,893 shares worth about $94.4 million for a 157.9% increase. Ameriprise Financial, Inc. reduced its holdings by 10,057 shares, ending with 6,694,797 shares worth about $82.1 million.

JBS N.V. Stock Down 4.0%

JBS N.V. recently traded around $11.96 as of October 22, 2026, down about 2.5% from its event-day close of $12.27. The stock trades below its 50-day moving average of $12.70 and its 200-day moving average of $14.17. Its 52-week trading range spans from a low of $10.61 to a high of $18.65.

12-month forecast

$JBS price target

JBS N.V. daily closes and this analyst's $17.50 target. Not advice.

Recent Earnings

For the trailing twelve-month period, JBS N.V. brought in $91.17 billion in revenue and generated $1.07 in earnings per share. The company reported a net profit margin of 1.2% and year-over-year revenue growth of 13.8%. Investors look ahead to the next earnings release scheduled for November 9, 2026.

Dividend

JBS N.V. pays an annual dividend rate of $1.00 per share, which yields 8.02% based on current trading levels. The company's dividend payout ratio stands at 93.5%.

Insider Buying and Selling at JBS N.V.

Guilherme Perboyre Cavalcanti, an officer at JBS N.V., sold 183,501 shares on August 24, 2026, at an average price of $13.85, totaling $2.54 million.

Analysts Set New Price Targets

Wall Street firms maintain active views on the company. UBS kept a Buy rating with a $17.50 target on August 24, 2026. Across the broader analyst community, 15 analysts hold opinions, resulting in a consensus buy recommendation and a mean price target of $18.43.

About JBS N.V.

Headquartered in Amstelveen, Netherlands, JBS N.V. operates as a major global processor of animal proteins, handling beef, pork, lamb, and poultry. Beyond meat processing, the company engages in prepared foods, leather, collagen, hygiene and beauty items, metal packaging, and biodiesel operations. The business employs 283,000 people worldwide under the leadership of CEO Gilberto Tomazoni.

Bottom Line

Market participants will monitor upcoming corporate announcements, including the scheduled earnings report on November 9, 2026, for further operational updates.

Source: JP Morgan's rating change on $JBS (Oct 22, 2026). Written by software, not financial advice. How we make alerts

Get $JBS trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions